Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis
Csernansky, J.G.; Vinogradov, S.; Prosser, E.; Kaplan, J.; Berger, P.A.; Hollister, L.E.
Psychopharmacology Bulletin 22(3): 897-899
1986
ISSN/ISBN: 0048-5764 PMID: 2879311 Document Number: 286199
Document emailed within 1 workday
Related Documents
Chouinard, G.; Annable, L.; Ross-Chouinard, A. 1986: Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients Psychopharmacology Bulletin 22(3): 891-896Staton, R.D.; Brumback, R.A. 1980: Neuroleptic-induced reinnervation sprouting in the central nervous system (a model for the development of tardive dyskinesia and supersensitivity psychosis) Journal of Clinical Psychiatry 41(12 Part 1): 427-428
Jeste, D.V.; Wyatt, R.J. 1981: Dogma disputed: is tardive dyskinesia due to postsynaptic dopamine receptor supersensitivity? Journal of Clinical Psychiatry 42(12): 455-457
Christensen, A.V.; Nielsen, I.M. 1980: Dopaminergic supersensitivity: influence of dopamine agonists and drugs used for the treatment of tardive dyskinesia Advances in Biochemical Psychopharmacology 24: 341-349
Gałecki, P.; Pietras, T.; Szemraj, J. 2006: Manganese superoxide dismutase gene (MnSOD) polimorphism in schizophrenics with tardive dyskinesia from central Poland Psychiatria Polska 40(5): 937-948
Bajulaiye, R.; Addonizio 1992: Clozapine in the treatment of psychosis in an 82-year-old woman with tardive dyskinesia Journal of Clinical Psychopharmacology 12(5): 364-365
Stone, J.P.; Holtzman, S.; Shellabarger, C.J. 1979: Neoplastic responses and correlated plasma prolactin levels in diethylstilbestrol-treated ACi and Sprague-Dawley rats Cancer Research 39(3): 773-778
Huh, L.; Lee, B.Ju. 2015: Efficacy of aripiprazole in antidepressants-induced tardive dystonia and tardive dyskinesia: a case report Psychiatria Danubina 27(2): 195-197
Camp, E.W. 1977: Tardive dyskinesia oral facial dyskinesia with moban Diseases of the Nervous System 38(9): 759
Gualtieri, C.T.; Sprague, R.L. 1984: Preventing tardive dyskinesia and preventing tardive dyskinesia litigation Psychopharmacology Bulletin 20(3): 346-348
Spritzer, P.M.; Barbosa-Coutinho, L.M.; Poy, M.; Orsi, V.; Dahlem, N.; Silva, I.S. 1995: Effects of norethisterone acetate and tamoxifen on serum prolactin levels, uterine growth and on the presence of uterine immunoreactive prolactin in estradiol-treated ovariectomized rats Brazilian Journal of Medical and Biological Research 28(1): 125-130
Chowdhury, K.L.; Jalali, R.K.; Abrol, A.; Saproo, R.K.; Shah, B.A.; Tramboo, R. 1991: Polypharmacy and tardive dyskinesia Journal of the Association of Physicians of India 39(6): 501-503
Granacher, R.P. 1978: The tardive dyskinesia syndrome Journal of the Kentucky Medical Association 76(1): 13-17
Mehta, D.; Eaton, J.; Burch, M.; Mehta, S. 1985: Observations in tardive dyskinesia Journal of Clinical Psychiatry 46(2): 73
Crane, G.E. 1971: More on amantadine in tardive dyskinesia New England Journal of Medicine 285(20): 1150-1151
Calne, D.B.; Claveria, L.E.; Teychenne, P.F.; Haskayne, L.; Lodge-Patch, I.C. 1974: Pimozide in tardive dyskinesia Transactions of the American Neurological Association 99: 166-170
Gunne, L.M.; Häggström, J.E.; Johansson, P.; Levin, E.D.; Terenius, L. 1988: Neurobiochemical changes in tardive dyskinesia L'Encephale 14(Special Issue): 167-173
Wolf, M.E.; DeWolfe, A.S.; Ryan, J.J.; Lips, O.; Mosnaim, A.D. 1985: Vulnerability to tardive dyskinesia Journal of Clinical Psychiatry 46(9): 367-368
Gunne, L.M.; Häggström, J.E. 1985: Experimental tardive dyskinesia Journal of Clinical Psychiatry 46(4 Pt 2): 48-50
Gardos, G.; Sokol, M.; Cole, J.O.; Sniffin, C. 1976: Eye color and tardive dyskinesia Psychopharmacology Bulletin 12(2): 7 8-7 9